A study has found that cholesterol-lowering pills may protect against glaucoma, according to reporting by Diario de Navarra. The Spanish newspaper described the result as an unexpected finding, publishing its report on Wednesday, 7 October 2026.
Glaucoma is an eye condition that damages the optic nerve and can lead to vision loss. The study points to a possible link between medications commonly prescribed to manage cholesterol levels and a reduced risk of developing the condition, Diario de Navarra reports. The outlet framed the connection as a surprising one, given that the drugs are normally associated with cardiovascular care rather than eye health.
The report did not include the full details of the research, such as the size of the study, the specific drugs examined, or the patient groups involved. Diario de Navarra presented the finding as the central result of the study, without elaborating on how the researchers explained the apparent protective effect.
The headline and summary alone do not establish whether the medications directly cause the lower glaucoma risk or whether other factors are at play. As with any single study, the finding would need to be weighed against broader evidence before it changes how doctors approach either cholesterol treatment or glaucoma prevention.
What to watch next: whether the researchers publish fuller data, and whether other groups replicate the link between cholesterol-lowering drugs and glaucoma risk.
